¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"stromal fatty ingrowth"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • epithelial ingrowth
    »óÇÇ´«¼ÓÁõ½Ä, »óÇǾȳ»Áõ½Ä
  • ingrowth
    1. ³»Áõ½Ä 2. ³»¼ºÀå
  • cortical stromal fibrosis
    °ÑÁú¹ÙÅÁÁú¼¶À¯Áõ, ÇÇÁú±âÁú¼¶À¯Áõ
  • endometrial stromal sarcoma
    Àڱ󻸷¹öÆÀÁúÀ°Á¾, Àڱ󻸷°£ÁúÀ°Á¾
  • gastrointestinal stromal tumor
    À§Ã¢ÀÚ±âÁúÁ¾¾ç, À§Àå°ü±âÁúÁ¾¾ç
  • stromal keratitis
    ¹öÆÀÁú°¢¸·¿°, °£Áú°¢¸·¿°
  • stromal luteoma
    ¹öÆÀÁúȲ(»ö)üÁ¾, °£ÁúȲ(»ö)üÁ¾
  • stromal tumor
    °£ÁúÁ¾¾ç, ¹öÆÀÁúÁ¾¾ç
  • sex cord-stromal tumor
    ¼º²ö±âÁúÁ¾¾ç, ¼º»è±âÁúÁ¾¾ç
  • essential fatty acid
    ÇʼöÁö¹æ»ê
  • fatty
    Áö¹æ-
  • fatty acid
    Áö¹æ»ê
  • fatty cast
    Áö¹æ¿øÁÖ
  • fatty change
    Áö¹æº¯È­
  • fatty cirrhosis
    Áö¹æ°£°æÈ­(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ingrowth
    1.³»Áõ½Ä, 2.³»¼ºÀå
  • sex cord-stromal tumor tumor
    ¼º²ö°£ÁúÁ¾¾ç, ³­¼Ò¹öÆÀÁúÁ¾¾ç
  • stromal tumor
    ¹öÆÀÁúÁ¾¾ç, ±âÁúÁ¾¾ç
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • fatty
    Áö¹æ-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • epithelial ingrowth
    »óÇÇ´«¼ÓÁõ½Ä, »óÇǾȳ»Áõ½Ä
  • ingrowth
    ³»Áõ½Ä
  • cortical stromal fibrosis
    °ÑÁú¹ÙÅÁÁú¼¶À¯Áõ, ÇÇÁú±âÁú¼¶À¯Áõ
  • endometrial stromal sarcoma
    Àڱ󻸷¹öÆÀÁúÀ°Á¾, Àڱ󻸷±âÁúÀ°Á¾
  • stromal keratitis
    ¹öÆÀÁú°¢¸·¿°, °£Áú°¢¸·¿°
  • stromal luteoma
    ¹öÆÀÁúȲüÁ¾
  • sex cord-stromal tumor
    (¢¡stromal tumor) ¼º²ö°£ÁúÁ¾¾ç, ³­¼Ò¹öÆÀÁúÁ¾¾ç
  • stromal tumor
    ¼º²ö°£ÁúÁ¾¾ç, ³­¼Ò¹öÆÀÁúÁ¾¾ç
  • essential fatty acid
    ÇʼöÁö¹æ»ê
  • fatty acid
    Áö¹æ»ê
  • free fatty acid
    À¯¸®Áö¹æ»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • sialic fatty acid
    ½Ã¾Ë»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • fatty cast
    Áö¹æ¿øÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gonadal stromal tumor
    ¼º¼±°£ÁúÁ¾¾ç
  • FA fatty acid
    Áö¹æ»ê.
  • FFA (free fatty acids)
    À¯¸®(ë´×î)Áö¹æ»ê(ò·Û¸ß«)
  • FFA= free fatty acid
    À¯¸®Áö¹æ»ê.
  • Fatty acid
    Áö¹æ»ê(ò·Û¸ß«)
  • Fatty acid-CoA
    Áö¹æ»ê(ò·Û¸ß«) ÄÚ¿£ÀÚÀÓA
  • Free fatty acids
    À¯¸®Áö¹æ»ê(ë´×îò·Û¸ß«)
  • free fatty acid
    À¯¸®Áö¹æ»ê.
  • free fatty acid.
    À¯¸®Áö¹æ»ê
  • polyunsaturate fatty acid
    ´Ù(Òý)ºÒÆ÷È­Áö¹æ»ê.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fatty ingrowth
    Áö¹æ ħÀ±(¡­öÙëÈ)
  • epithelial ingrowth
    »óÇÇ´«¼ÓÁõ½Ä, »óÇǾȳ»Áõ½Ä
  • cortical stromal fibrosis
    ÇÇÁú°£Áú¼¶À¯È­(¡­Êàòõàéë«ûù)
  • early stromal invasion
    Á¶±â°£Áúħ¹ü(À±)
  • endolymphatic stromal myosis
    ¸²ÇÁ°ü³» °£Áú¼º ±ÙÁ¾
  • endometrial stromal sarcoma
    Àڱ󻸷 °£ÁúÀ°Á¾
  • endometrium,stromal tumors
    ±âÁú Á¾¾ç
  • gonadal stromal tumor
    ¼º¼±°£ÁúÁ¾¾ç
  • sex cord-stromal tumor
    ¼º±â»è°£ÁúÁ¾¾ç(àõÐï»è°£ÁúðþåË)
  • stromal cell
    °£Áú¼¼Æ÷(Êàòõá¬øà).
  • stromal corneal dystrophy
    °¢¸·°£ÁúÀÌ¿µ¾ç(Áõ)
  • stromal keratitis
    °£Áú°¢¸·¿°
  • stromal luteoma
    ±âÁú¼º(°£Áú¼º)ȲüÁ¾(Ðñòõà÷(Êàòõàõ)üÜô÷ðþ)
  • stromal tumor of endometrium
    Àڱ󻸷(ÀڱüӸ·)ÀDZâÁú¼ºÁ¾¾ç(í­ÏàҮد(í­Ïà¼Óد)¡­ÐñòõàõðþåË)
  • atherosclerosis,fatty sterak
    Áö¹æ¼±Á¶(ò·Û¸¼±Á¶)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-fatty-liver-factor
    Ç×Áö¹æ°£ÀÎÀÚ(ù÷ò·Û¸ÊÜì×í­)
  • branched fatty acid
    ºÐÁöÁö¹æ»ê(ÝÂò«ò·Û¸ß«)
  • essential fatty acid
    Çʼö Áö¹æ»ê (ù±âÎò·Û¸ß«)
  • even-numbered fatty acid
    ¦¼ö Áö¹æ»ê(ß«)
  • fatty acid
    Áö¹æ»ê(ò·Û¸ß«)
  • fatty acid activating enzyme
    Áö¹æ»ê Ȱ¼ºÈ­ È¿¼Ò (ò·Û¸ß«üÀàõûùý£áÈ)
  • fatty acid activation
    Áö¹æ»ê Ȱ¼ºÈ­ (ò·Û¸ß«üÀàõûù)
  • fatty acid CoA ligase
    Áö¹æ»ê(ò·Û¸ß«) CoA ¶óÀ̰ÔÀ̽º
  • fatty acid oxidation
    Áö¹æ»ê »êÈ­ (ò·Û¸ß«ß«ûù)
  • fatty acid synthetase system
    Áö¹æ»ê ÇÕ¼º È¿¼Ò(ò·Û¸ß«ùêà÷ý£áÈ)½Ã½ºÅÛ
  • fatty acid thiokinase
    Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
  • fatty acyl group
    Áö¹æ(ò·Û¸) ¾Æ½Ç±â(Ðñ)
  • fatty alcohol
    Áö¹æ(ò·Û¸) ¾ËÄÚ¿Ã
  • fatty degeneration
    Áö¹æÅðÇà(ò·Û¸÷Üú¼)
  • fatty infiltration
    Áö¹æÄ§À±(ò·Û¸öÕëÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • stromal cell
    °£Áú¼¼Æ÷
  • fatty
    Áö¹æÀÇ
  • fatty degeneration
    Áö¹æº¯¼º
  • fatty liver
    Áö¹æ°£
  • fatty marrow
    Áö¹æ°ñ¼ö, Áö¹æ¼ö
  • fatty metamorphosis
    Áö¹æº¯È­, Áö¹æº¯¼º, Áö¹æº¯
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FAP familial adenomatous polyposis; familial amyloid polyneuropathy; fatty acid polyunsaturated; fatty a...
CSH carotid sinus hypersensitivity; chronic subdural hematoma; combat support [army] hospital; cortical ...
MSC marrow stromal cell; Medical Service Corps; Medical Staff Corps
SCL scleroderma; serum copper level; sinus cycle length; soft contact lens; stromal cell line; subcostal...
TUGSE traumatic ulcerative granuloma with stromal eosinophilia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HSI Hippocampal sympathetic ingrowth
BMSC Bone marrow stromal cell
ESS Endometrial Stromal Sarcoma
GIST Gastro Intestinal Stromal Tumors
HSK Herpetic stromal keratitis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • endometrial stromal sarcoma
    Àڱ󻸷 ±âÁú À°Á¾
    Àú¾Ç¼º°ú °í¾Ç¼º Á¾¾çÀ¸·Î ±¸ºÐµÈ´Ù. Æò±Õ ¿¬·ÉÀº 42-53¼¼ÀÌ°í ¹Ý¼ö À̻󿡼­ Æó°æ±â ÀÌÀü¿¡ »ý±ä´Ù. ÁÖ Áõ»óÀº ÀÌ»ó ÀÚ±ÃÃâÇ÷, ÁÖ±âÀû ºÎÁ¤ Àڱà ÃâÇ÷ ¹× º¹ºÎ µ¿Åë µîÀÌ´Ù. ÈçÈ÷ ÀÚ±ÃÀÌ Ä¿Áö¹Ç·Î ÀÓ»óÀûÀ¸·Î ÀڱñÙÁ¾À¸·Î Áø´ÜµÉ ¶§°¡ ¸¹´Ù. À°¾ÈÀûÀ¸·Î Àú¾Ç¼ºÀº Àß °æ°èµÇÁö ¾Ê´Â Á¾±«°¡ ÁÖÀ§ÀÇ ±ÙÃþÀ¸·Î Ȳ°¥»öÀÇ ¼Ò°áÀýó·³ ħÀ±Çذ¡´Â °Í°ú ¶Ñ·ÇÇÑ Á¾±« Çü¼º ¾øÀÌ ÀڱñÙÃþÀÌ ¹Ì¸¸¼ºÀ¸·Î ºñÈĵǴ °Í, Á¾±«°¡ ±ÙÁ¾Ã³·³ ÁÖº¯ ºÎÀ§¿¡¼­ À¶±âµÇ¾î º¸ÀÌÁö¸¸ Àý´Ü¸éÀÌ È²°¥»öÀÌ°í ¿¬ÇÏ¿© ±ÙÁ¾°ú´Â ´Ù¸¥ °æ¿ìÀÇ ¼¼ °¡Áö ÇüŸ¦ ÃëÇÑ´Ù. °í¾Ç¼ºÀº ¿¬ÇÏ°í °í±â µ¢¾î¸® °°Àº ¿ëÁ¾¼º Á¾¾çÀ¸·Î Àڱó» °­ ¾ÈÀ¸·Î ÅÍÁ® ³ª¿Í ³»°­À» ä¿ì°Ô µÈ´Ù. ´Ù¹ß¼ºÀ̰í ÃâÇ÷°ú ±«»ç¸¦ ÈçÈ÷ º¸À̸ç Àڱñ٠ÃþÀ¸·Î ħÀ±ÇÑ´Ù.
  • questionable stromal invasion
    °£Áú ħ¹üÀÇ ÀǽÉÀÌ ÀÖ´Â
  • essential fatty acid
    Çʼö Áö¹æ»ê
    °íµîµ¿¹°ÀÇ ¼ºÀå ¶Ç´Â °Ç°­ »óÅÂÀÇ À¯Áö¸¦ À§ÇÏ¿© ü¿Ü·ÎºÎÅÍ ¼·ÃëÇØ¾ß ÇÒ Áö¹æ»ê. ºñŸ¹Î F¶ó°íµµ ÇÑ´Ù. Áö¹æÀº ü³»¿¡¼­ ÁÖ·Î ¿¡³ÊÁö¿øÀÌ µÇ¹Ç·Î ´Ù¸¥ °ÍÀ¸·ÎºÎÅÍ Ä®·Î¸®¸¦ ÃëÇϸé Áö¹æÀº ÇÊ¿ä¾øÁö ¾ÊÀº°¡ ÇÏ´Â Àǹ®ÀÌ »ý±ä´Ù. ±×·¯³ª À½½Ä ¼Ó¿¡ Áö¹æÀÌ ÀüÇô ¾øÀ¸¸é µ¿¹°ÀÇ ¼ºÀåÀÌ Á¤ÁöÇÏ°í Æ¯À¯ÇÑ ÇǺο°ÀÌ »ý±ä´Ù. ÀÌ Áõ¼¼´Â ¸®³î»ê, ¸®³î·»»ê, ¾Æ¶ó۵·»ê Áß ¾î´À °ÍÀ» ÇÔÀ¯ÇÏ´Â Áö¹æÀ» Åõ¿©Çϸé Ä¡À¯µÈ´Ù. ±×·¡¼­ À̵é Áö¹æÀ» ¾Æ¹Ì³ë»êÀÇ ¿¹¿¡ µû¶ó Çʼö Áö¹æ»êÀ̶ó°í ÇÑ´Ù. ÀÌ»óÀÇ ¼¼ °¡Áö Áö¹æ»ê Áß¿¡¼­ ¸®³î»êÀº ÀϹÝÀûÀÎ À¯Áö¿¡ ³Î¸® ÇÔÀ¯µÇ¾î ÀÖÀ¸¹Ç·Î, º¸ÅëÀÇ Áö¹æÀ» ¼·ÃëÇϸé Áö¹æ»êÀÌ °áÇÌÇÏ´Â ÀÏÀº ¾ø´Ù.
  • fatty
    Áö¹æÀÇ
  • fatty acid cyclooxygenase
    Áö¹æ»ê »çÀÌŬ·Î¿Á½ÃÁö³×À̽º
  • fatty body
    Áö¹æ ¼Òü
  • fatty coating of surface
    Ç¥¸éÀÌ Áö¹æÀ¸·Î µ¤Çô ÀÖ´Â
  • fatty film
    Áö¹æÃþ, Áö¹æ ¸·
  • fatty infiltration
    Áö¹æ ħÀ±
  • fatty liver
    Áö¹æ °£
    ¼ú, °ú½Ä, ºñ¸¸, ´ç´¢º´, ¾à¹° µîÀÇ ¿øÀο¡ ÀÇÇØ °£ ¼¼Æ÷¿¡ Áö¹æÀÌ °ú´Ù ÃàÀûµÇ¾î Á¦ ±â´ÉÀ» ¸øÇÏ´Â »óÅÂ.
  • fatty metamorphosis
    Áö¹æ º¯È­, Áö¹æ º¯¼º, Áö¹æ º¯
  • fatty streak
    Áö¹æ¼º ¶ì, Áö¹æ ¼±Á¶
    µ¿¸Æ³»¿¡ ÁÖ·Î ÄÝ·¹½ºÅ×·Ñ¿¡ ÀÇÇÏ¿© ±¸¼ºµÈ ÀÛÀº ÆíÆòÇÑ È²È¸»ö ºÎÀ§. ¾Æ¸¶µµ Á×»ó µ¿¸Æ °æÈ­ÁõÀÇ ÃʱâÀÏ °ÍÀÌ´Ù. Á÷°æÀÌ 1mm ÀÌÇÏÀÎ ´Ù¹ß¼º Ȳ»ö Á¡À¸·Î ½ÃÀÛÇÏ¸ç ÆøÀÌ 1-2mmÀÌ°í ±æÀ̰¡ 1cm Á¤µµÀÇ ¼±Á¶°¡ µÈ´Ù. Áö¹æ ¼±Á¶´Â ÁöÁú·Î ±¸¼ºµÈ Æ÷¸» ¼¼Æ÷·Î ±¸¼ºµÇ¾î ÀÖ´Ù. T-¼¼Æ÷, ¼¼Æ÷ÀÇ ÁöÁúÀÌ Á×Á¾¼º ÆÇº¸´Ù Àû°Ô ÀÖ°í, ÇÁ·ÎÅ׿À±Û¸®Ä­, ÄݶóÁ¨ ¹× ź·Â ¼¶À¯µµ ´Ù¾çÇÑ Á¤µµ·Î Á¸ÀçÇÑ´Ù. Áö¿ª, ÀÎÁ¾, ¼ºº° ȤÀº ȯ°æ¿¡ °ü°è¾øÀÌ 1³â ÀÌ»óµÈ ¼Ò¾ÆÀÇ ´ëµ¿¸Æ¿¡ ³ªÅ¸³ª°í °ü»ó µ¿¸Æ Áö¹æ ¼±Á¶´Â »çÃá±â¿¡ ½ÃÀ۵Ǹç, Á×Á¾¼º ÆÇÀÌ ¹ß»ýµÇ´Â ÇØºÎÇÐÀûÀÎ À§Ä¡¿Í ÀÏÄ¡ÇÑ´Ù.
  • free fatty acid
    À¯¸® Áö¹æ»ê
  • no fatty coating
    ºñ Áö¹æ¼º ÇǺ¹
  • polyunsaturate fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
sarcoma, endometrial stromal A highly malignant neoplasm of the endometrium, arising from the endometrial stroma. It represents one type of stromal tumour, the other being endolymphatic stromal myosis. They are differentiated on the basis of the number of mitoses per 10 high power fields: endometrial stromal sarcoma has 10 or more mitoses, endolymphatic stromal myosis fewer. Stroma sarcoma is seen most often between the ages of 45 and 50. (devita jr et al., cancer: principles & practice of oncology, 3d ed, p1146)
(12 Dec 1998)
sex cord-stromal tumour A malignant neoplasm of the ovary or testis. These tumours differentiate toward sex cords (in embryonic gonads) in the form of female (i.e., granulosa and theca) cells, male (i.e., sertoli and leydig) cells, or indifferent elements. In the ovary, sex cord-stromal tumours comprise 5% of all ovarian neoplasms. In the testes, leydig and sertoli cell tumours comprise about 5% of all testicular neoplasms, 10% of which behave in a malignant fashion.
(12 Dec 1998)
stromal Stromatic; relating to the stroma of an organ or other structure.
Synonym: stromic.
(05 Mar 2000)
stromal cells Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the haematopoietic system and elsewhere.
(12 Dec 1998)
stromal hyperthecosis Condition in which luteinised cells are present in ovarian stroma at a distance from follicular structures.
(05 Mar 2000)
stromal processing peptidase <enzyme> Involved in processing chloroplast stromal proteins
Registry number: EC 3.4.24.-
(26 Jun 1999)
ovarian stromal tumours <radiology> Age 20 - 50 yrs, 20% of all ovarian tumours, fibroma / fibrosarcoma, granulosa-theca cell tumour, with or without oestrogens most likely to be precocious puberty, endometrial hyperplasia/carcinoma, fibrocystic breast disease, Sertoli-Leydig cell tumour, aka: arrhenoblastoma, with or without androgens most likely to be masculinization, may be mixed type
(12 Dec 1998)
endometrial stromal sarcoma <tumour> A term sometimes used for a relatively rare sarcoma believed to be a form of endometriosis in which the lesions form multiple foci in the myometrium and in vascular spaces in other sites, and which consist of histologic and cytologic elements that resemble those of the endometrial stroma.
Synonym: stromatosis.
(05 Mar 2000)
activated fatty acid A fatty acyl-coenzyme A thiol ester.
(05 Mar 2000)
branched-chain fatty-acid-kinase <enzyme> From anaerobic spirochete ma-2
Registry number: EC 2.7.2.14
Synonym: isovalerate kinase, 2-methylbutyrate kinase, isobutyrate kinase
(26 Jun 1999)
branched-chain fatty acid synthetase <enzyme> Analogous to fatty acid synthetase complex but starting with a branched chain keto acid; from bacillis subtilis
Registry number: EC 2.3.1.-
Synonym: bcfa synthetase
(26 Jun 1999)
volatile fatty acid number An index of the volatile acid content of a fat; the number of milliliters of 0.1 n KOH required to neutralise the soluble volatile fatty acids in 5 g of fat that has been saponified, acidified to liberate the fatty acids, and then steam-distilled.
Synonym: volatile fatty acid number.
(05 Mar 2000)
monounsaturated fatty acids A fatty acid chain with at least two empty spaces that could be hydrogenated (have a hydrogen atom added). Saturated (hydrogenated) fatty acids are a greater health risk for the development of atherosclerotic vascular disease.
(27 Sep 1997)
polyenoic fatty acid isomerase <enzyme> Catalyses conversion of arachidonic acid and 5,8,11,14,17-eicosapentaenoic acid to 5,7,9,14-eicosatetraenoic acid and 5,7,9,14,17-eicosapentaenoic acid, respectively
Registry number: EC 5.3.3.-
Synonym: pfi enzyme
(26 Jun 1999)
saturated fatty acid A fatty acid, the carbon chain of which contains no ethylenic or other unsaturated linkages between carbon atoms (e.g., stearic acid and palmitic acid); called saturated because it is incapable of absorbing any more hydrogen.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ingrowth
    ¾ÈÀ¸·Î ÀÚ¶÷
  • fatty
    ±â¸§±â°¡ ¸¹Àº;Áö¹æ °ú´Ù(Áõ)ÀÇ;¶×º¸
  • fatty acid
    Áö¹æ»ê
  • fatty degeneration
    Áö¹æ º¯Áú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á